3B Films (544412)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹20.1 |
| Market Cap | ₹49.79 Cr |
| P/E Ratio | 45.68 |
| ROCE | 8.55% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -131.56% |
| Debt/Equity | — |
| Sales Growth | -44.57% |
| Sector | Industrial Products |
Strengths
- Latest quarter still managed ₹26 crore of sales, proving some operating revenue remains.
- ROCE is positive at 8.55%, so existing capital is generating a modest operating return.
- Small ₹50 crore market cap offers scope for a meaningful recovery if execution improves.
- Zero dividend payout preserves cash at a time when operations are under stress.
Concerns
- Sales growth of -44.57% indicates severe demand or competitive deterioration.
- Net profit fell 131.56% and latest quarter is loss-making at -₹1 crore.
- Piotroski F-Score of 3/9 points to weak financial health.
- P/E of 45.68 is unjustified with collapsing earnings; lack of book value, promoter holding, and dividend data impairs analysis.
AI Analysis
Looking at 3B Films, I am immediately reminded of Graham's warning: when the facts are missing, enthusiasm is dangerous. This is a ₹50 crore market-cap packaging business trading at ₹20.10 with a trailing P/E of 45.68. But that multiple is an illusion because the earnings behind it are evaporating. Sales are down 44.57%, profits are down 131.56%, and the latest quarter shows a net loss of ₹1 crore on sales of ₹26 crore. No rational investor should pay 45 times earnings for a company whose earnings are turning negative. The positive ROCE of 8.55% shows the capital base isn't completely sterile, but it is far below what I require for a growing, competitive business. The Piotroski F-Score of 3/9 reinforces my unease: this is a financially weak company. I also have no book value, no ROE, no promoter holding data, and no dividend. In the absence of these basics, the margin of safety is impossible to calculate. Packaging may be a functional industry, but I see no moat here. A small client base, pricing pressure, or a cyclical downturn could all explain such a sharp revenue fall; the numbers alone do not tell me which. The only way this becomes interesting is as a turnaround: if quarterly sales stabilise and the company earns a real profit, the low absolute valuation could become attractive. But until I see several quarters of evidence, this is speculation, not investment. My discipline is to wait for a better price and far better financial health. I will not chase a loss-making enterprise at a rich multiple merely because the stock is cheap in absolute rupees.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer